Ichor Biologics - About the company
Ichor Biologics is a funded company based in Hyderabad (India), founded in 2011. It operates as a Developer of plasma-derived biopharmaceuticals for health conditions. The company has 2668 active competitors, including 896 funded and 659 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Blueprint Medicines.
Company Details
Developer of plasma-derived biopharmaceuticals for health conditions. The company offers a range of products including critical care products, immunoglobulins, hemophilia care products, and wound healing products.
- Website
- ichor.in
- Email ID
- *****@ichor.in
- Registered Address
- Sy. No. 222P, Thurkapally Village, Shameerpet Mandal, Rangareddi, Medchal Malkajgiri, Telangana, India, 500078
Key Metrics
Founded Year
2011
Location
Hyderabad, India
Stage
Funding Raised
Ranked
1377th among 2668 active competitors
Annual Revenue
₹124Cr as on Mar 31, 2025
Employee Count
310 as on Aug 31, 2025
Similar Companies
Legal entities associated with Ichor Biologics
Ichor Biologics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ICHOR BIOLOGICS PRIVATE LIMITED CIN: U24239TG2021PTC149331 , India, Active | Mar 05, 2021 | $14.7M (As on Mar 31, 2025) | 310 (As on Aug 01, 2025) |
Sign up to download Ichor Biologics' company profile
Ichor Biologics's funding and investors
Ichor Biologics is a funded company.
Ichor Biologics' founders and board of directors
Founder? Claim ProfileIchor Biologics' Board of Directors
Ichor Biologics's board has 2 active members. Anand Reddy Sudini is part of team and Sujana Sudini is independent board member.Here is the list of Ichor Biologics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
tawitsb | Team | - | Current | 4y 2m |
Independent board member | - | Current | 5y 2m |
Ichor Biologics' employee count trend
Ichor Biologics has 310 employees as of Aug 25. Here is Ichor Biologics's employee count trend over the years:
Uncover Ichor Biologics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ichor Biologics's Competitors and alternates
Top competitors of Ichor Biologics include Jazz Pharmaceuticals, Sana Biotechnology and Blueprint Medicines. Here is the list of Top 10 competitors of Ichor Biologics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 75/100 | |
3rd | Blueprint Medicines 2008, Cambridge (United States), Acquired | Developer of selective kinase inhibitors for patients with genomically defined cancers | $115M | 72/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 72/100 | |
5th | _1548135965397.png?devicePixelRatio=2&height=30&width=30){kind=logo} Kronos Bio 2017, San Mateo (United States), Acquired | Developer of small molecule based therapeutics for cancer treatment | $271M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th | Karyopharm 2008, Natick (United States), Public | Developer of small molecule drugs for the treatment of cancer and inflammatory disease | $98.4M | 71/100 | |
9th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
10th | Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer | $146M | 71/100 | ||
1377th | Ichor Biologics 2011, Hyderabad (India), Funding Raised | Developer of plasma-derived biopharmaceuticals for health conditions | - | - | 31/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Ichor Biologics's competitors? Click here to see the top ones
Ichor Biologics's Investments and acquisitions
Ichor Biologics has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Ichor Biologics
Explore our recently published companies
- Houttek - Nijverdal based, 2004 founded, Unfunded company
- Vaststructural - Unfunded company
- DVA-Engineering BV - Netherlands based, 2004 founded, Unfunded company
- Bergpiscine - Italy based, Unfunded company
- Chevin Geoenviro Associates Ltd - Leeds based, 2014 founded, Unfunded company
- Easy Street - India based, Unfunded company
